Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bhaskar Dasgupta

Showing results (121-130 of 204) with videos related to

Pageof 21
Sort By:
Annals of the Rheumatic Diseases|June 24, 2020
Response to: 'Diagnostic accuracy of novel ultrasonographic halo score for giant cell arteritis: methodological issues' by Ghajari and SabourKornelis Sm van der Geest, Frances Borg, Abdul Kayani, et al.
Autoimmunity Reviews|December 7, 2024
Targeting interleukin-6 pathways in giant cell arteritis management: A narrative review of evidenceMaxime Samson, Bhaskar Dasgupta, Anthony M Sammel, et al.
The Journal of Rheumatology|April 17, 2016
Which Patients with Giant Cell Arteritis Will Develop Cardiovascular or Cerebrovascular Disease? A Clinical Practice Research Datalink StudyJoanna C Robson, Amit Kiran, Joe Maskell, et al.
Annals of the Rheumatic Diseases|January 5, 2020
Novel ultrasonographic Halo Score for giant cell arteritis: assessment of diagnostic accuracy and association with ocular ischaemiaKornelis S M van der Geest, Frances Borg, Abdul Kayani, et al.
The Journal of Rheumatology|June 3, 2009
E-selectin, interleukin 18, serum amyloid a, and matrix metalloproteinase 9 are associated with clinical response to golimumab plus methotrexate in patients with active rheumatoid arthritis despite methotrexate therapySudha Visvanathan, Carrie Wagner, Jeannie Rojas, et al.
International Journal of Rheumatic Diseases|August 10, 2017
A 26-week feasibility study comparing the efficacy and safety of modified-release prednisone with immediate-release prednisolone in newly diagnosed cases of giant cell arteritisCharles Raine, Philip P Stapleton, Dimos Merinopoulos, et al.
Annals of the Rheumatic Diseases|October 8, 2013
The relative risk of aortic aneurysm in patients with giant cell arteritis compared with the general population of the UKJoanna C Robson, Amit Kiran, Joe Maskell, et al.
Rheumatology and Therapy|August 27, 2020
A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Sirukumab in the Treatment of Giant Cell ArteritisWolfgang A Schmidt, Bhaskar Dasgupta, Raashid Luqmani, et al.
Journal of Bioinformatics and Computational Biology|April 20, 2010
Combinatorial reconstruction of half-sibling groups from microsatellite dataSaad I Sheikh, Tanya Y Berger-Wolf, Ashfaq A Khokhar, et al.
BMC Rheumatology|August 22, 2020
Halo score (temporal artery, its branches and axillary artery) as a diagnostic, prognostic and disease monitoring tool for Giant Cell Arteritis (GCA)Alwin Sebastian, Kornelis S M van der Geest, Fiona Coath, et al.
Pageof 21

Showing results (121-130 of 204) with videos related to

Sort By:
Pageof 21
Annals of the Rheumatic Diseases|June 24, 2020
Response to: 'Diagnostic accuracy of novel ultrasonographic halo score for giant cell arteritis: methodological issues' by Ghajari and SabourKornelis Sm van der Geest, Frances Borg, Abdul Kayani, et al.
Autoimmunity Reviews|December 7, 2024
Targeting interleukin-6 pathways in giant cell arteritis management: A narrative review of evidenceMaxime Samson, Bhaskar Dasgupta, Anthony M Sammel, et al.
The Journal of Rheumatology|April 17, 2016
Which Patients with Giant Cell Arteritis Will Develop Cardiovascular or Cerebrovascular Disease? A Clinical Practice Research Datalink StudyJoanna C Robson, Amit Kiran, Joe Maskell, et al.
Annals of the Rheumatic Diseases|January 5, 2020
Novel ultrasonographic Halo Score for giant cell arteritis: assessment of diagnostic accuracy and association with ocular ischaemiaKornelis S M van der Geest, Frances Borg, Abdul Kayani, et al.
The Journal of Rheumatology|June 3, 2009
E-selectin, interleukin 18, serum amyloid a, and matrix metalloproteinase 9 are associated with clinical response to golimumab plus methotrexate in patients with active rheumatoid arthritis despite methotrexate therapySudha Visvanathan, Carrie Wagner, Jeannie Rojas, et al.
International Journal of Rheumatic Diseases|August 10, 2017
A 26-week feasibility study comparing the efficacy and safety of modified-release prednisone with immediate-release prednisolone in newly diagnosed cases of giant cell arteritisCharles Raine, Philip P Stapleton, Dimos Merinopoulos, et al.
Annals of the Rheumatic Diseases|October 8, 2013
The relative risk of aortic aneurysm in patients with giant cell arteritis compared with the general population of the UKJoanna C Robson, Amit Kiran, Joe Maskell, et al.
Rheumatology and Therapy|August 27, 2020
A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Sirukumab in the Treatment of Giant Cell ArteritisWolfgang A Schmidt, Bhaskar Dasgupta, Raashid Luqmani, et al.
Journal of Bioinformatics and Computational Biology|April 20, 2010
Combinatorial reconstruction of half-sibling groups from microsatellite dataSaad I Sheikh, Tanya Y Berger-Wolf, Ashfaq A Khokhar, et al.
BMC Rheumatology|August 22, 2020
Halo score (temporal artery, its branches and axillary artery) as a diagnostic, prognostic and disease monitoring tool for Giant Cell Arteritis (GCA)Alwin Sebastian, Kornelis S M van der Geest, Fiona Coath, et al.
Pageof 21